Brooks O'Neil
Stock Analyst at Lake Street
(1.23)
# 3,485
Out of 4,761 analysts
31
Total ratings
38.71%
Success rate
-13.23%
Average return
Main Sectors:
Stocks Rated by Brooks O'Neil
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SMLR Semler Scientific | Maintains: Buy | $40 → $71 | $47.74 | +48.72% | 1 | Jan 24, 2025 | |
| MODV ModivCare | Maintains: Buy | $30 → $10 | $5.05 | +98.02% | 3 | Jan 13, 2025 | |
| RCEL AVITA Medical | Maintains: Buy | $20 → $14 | $9.75 | +43.59% | 6 | Jan 8, 2025 | |
| LFVN LifeVantage | Initiates: Buy | $26 | $16.69 | +55.78% | 1 | Dec 19, 2024 | |
| LFMD LifeMD | Initiates: Buy | $12 | $5.46 | +119.78% | 1 | Dec 10, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $55 | $28.95 | +89.98% | 3 | Oct 4, 2024 | |
| ATEC Alphatec Holdings | Maintains: Buy | $32 → $18 | $10.61 | +69.65% | 4 | Sep 3, 2024 | |
| ORGO Organogenesis Holdings | Initiates: Buy | $5 | $3.21 | +55.76% | 1 | Jun 28, 2024 | |
| SRDX Surmodics | Downgrades: Hold | $43 | $34.85 | +23.39% | 3 | May 29, 2024 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $60 → $75 | $31.00 | +141.94% | 1 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $4.5 | $0.21 | +2,061.38% | 1 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $7.98 | +50.38% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $75 | $99.54 | -24.65% | 1 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $26 | $27.97 | -7.04% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $45 | $3.60 | +1,150.00% | 1 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $1.08 | +918.52% | 1 | Apr 8, 2022 |
Semler Scientific
Jan 24, 2025
Maintains: Buy
Price Target: $40 → $71
Current: $47.74
Upside: +48.72%
ModivCare
Jan 13, 2025
Maintains: Buy
Price Target: $30 → $10
Current: $5.05
Upside: +98.02%
AVITA Medical
Jan 8, 2025
Maintains: Buy
Price Target: $20 → $14
Current: $9.75
Upside: +43.59%
LifeVantage
Dec 19, 2024
Initiates: Buy
Price Target: $26
Current: $16.69
Upside: +55.78%
LifeMD
Dec 10, 2024
Initiates: Buy
Price Target: $12
Current: $5.46
Upside: +119.78%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $28.95
Upside: +89.98%
Alphatec Holdings
Sep 3, 2024
Maintains: Buy
Price Target: $32 → $18
Current: $10.61
Upside: +69.65%
Organogenesis Holdings
Jun 28, 2024
Initiates: Buy
Price Target: $5
Current: $3.21
Upside: +55.76%
Surmodics
May 29, 2024
Downgrades: Hold
Price Target: $43
Current: $34.85
Upside: +23.39%
Tandem Diabetes Care
May 22, 2024
Maintains: Buy
Price Target: $60 → $75
Current: $31.00
Upside: +141.94%
Mar 14, 2024
Maintains: Buy
Price Target: $9 → $4.5
Current: $0.21
Upside: +2,061.38%
Mar 7, 2024
Initiates: Buy
Price Target: $12
Current: $7.98
Upside: +50.38%
Aug 2, 2023
Maintains: Buy
Price Target: $65 → $75
Current: $99.54
Upside: -24.65%
Feb 15, 2023
Maintains: Buy
Price Target: $20 → $26
Current: $27.97
Upside: -7.04%
Nov 21, 2022
Assumes: Buy
Price Target: $45
Current: $3.60
Upside: +1,150.00%
Apr 8, 2022
Initiates: Buy
Price Target: $11
Current: $1.08
Upside: +918.52%